Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily C member 2 (KCNC2) is a protein-coding gene that encodes a voltage-gated potassium channel, primarily expressed in the brain. It belongs to the delayed rectifier class of potassium channels and plays a critical role in mediating the voltage-dependent permeability of excitable membranes to potassium ions. The main physiological function of KCNC2 is to enable rapid repolarization during action potentials, supporting high-frequency neuronal firing without significant accommodation or fatigue. Mutations or dysfunctions in KCNC2 have been linked to neurological disorders such as Developmental And Epileptic Encephalopathy 103 and other developmental epileptic encephalopathies.
Modulates neuronal excitability by regulating potassium ion flow across cell membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily C member 2 (KCNC2).